Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Non-cash Items (2024 - 2025)

Historic Non-cash Items for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $400000.0.

  • Neuphoria Therapeutics' Non-cash Items rose 30000.0% to $400000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $400000.0, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $64485.0 for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Neuphoria Therapeutics' Non-cash Items stood at $400000.0, which was up 30000.0% from $600000.0 recorded in Q3 2025.
  • Neuphoria Therapeutics' Non-cash Items' 5-year high stood at $79.9 million during Q3 2024, with a 5-year trough of $44601.0 in Q1 2025.